CG Products Bucket

  1. Single-Use Solutions: Cryopreservation 6/26/2025

    As advanced therapy manufacturing evolves, maintaining the integrity of biological materials during cryopreservation steps is ever more critical.

  2. Single-Use Solutions: Cell Growth 6/26/2025

    From early-stage research to commercial-scale production, Charter Medical delivers integrated solutions that streamline your biopharma workflows.

  3. Single-Use Solutions: Biological Fluid Management 6/26/2025

    Ensure efficiency in your upstream and downstream biopharma workflows with Charter Medical’s biological fluid management solutions.

  4. Imaging And Analysis System For 3D Cell Cultures 6/25/2025

    The Cell3iMager series instruments are imaging systems that capture and analyze 2D and 3D cultured cells at high-speed using SCREEN’s unique optical system and image processing technology.

  5. Live Cell Metabolic Analyzer 6/25/2025

    LiCellMo is available for purchase in the U.S., Canada, and select other geographies globally. For research and education use only, not for use in diagnostic procedures in the U.S. or Canada. This product has not been approved or cleared as a medical device by the U.S. Food and Drug Administration or Health Canada.

  6. Cell Expansion Bioreactor System 6/25/2025

    Visualize continuous metabolic changes in cells in real-time and adjust cell culture conditions automatically for enhanced cell quality.

  7. Environmental Monitoring For Aseptic Filling Operations 6/16/2025

    AST’s aseptic processing solutions are outfitted with the latest in intuitive cGMP technology designed to optimize the fill-finish process for the highest standards of quality and regulatory compliance.

  8. Atmos Isolator For Fill/Finish Applications 6/16/2025

    A technically superior, cGMP-compliant product, the AST Atmos Isolator features a groundbreaking user-friendly design, enhanced automation and efficiency, robust sterility assurance, and a disruptive VPHP solution providing industry-leading bio-decontamination cycle times.

  9. Immunotherapy Development 6/10/2025

    Immunotherapy is an evolving and promising cancer treatment that works by stimulating the immune system. More biologically relevant human primary cells are now the chosen starting material for immunotherapy development. Historically, scientists routinely used immortalized cell lines in the research and development of therapies as they offer an inexpensive and stable platform. However, they are not fully representative of what is going on in vivo.

  10. Allogeneic CAR-T Cells 6/10/2025

    Allogeneic CAR-T Cells Vs Autologous

    Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Clinical trials with autologous CAR-T cells have shown very promising results and led to the approval of numerous CAR-T cell therapies.